Electroceuticals derived from electronic and pharmaceuticals is a term coined to describe the therapeutic manipulation of neuronal signaling. In recent years, the sophistication and range of applications of electroceuticals has grown considerably. In this Review we therefore suggest a revised ontology and framework for defining electroceuticals that broadens the concept beyond neuron‐targeted interventions. This more inclusive framework aims to provide greater coherence and bring together different stakeholders to accelerate progress in this field. We suggest that electroceuticals can be categorised according to the level of physiology for which they act: cellular, tissue, organ and systemic. We discuss emerging developments for each category of electroceutical and future directions from a pharmaceutical industry perspective. We also highlight potential challenges for translation of electroceuticals, such as a lack of clinical biomarkers and incomplete understanding of mechanisms of action and offer solutions for stimulating progress in this exciting field.This article is protected by copyright. All rights reserved